Answers are grounded in this paper and cite their sources.
Substantial variability in organoid differentiation into well-defined target cell populations necessitates objective, nondestructive quality assessment early during differentiation to support successful organoid-based therapies. We propose a triplet-trained Vision Transformer (Triplet-ViT) to predict differentiation outcomes of hypothalamic–pituitary organoids using a publicly available dataset comprising 1500 bright-field images and compare its performance with EfficientNetV2-S and their 50:50 ensemble. Triplet-ViT was also compared with a CE-only ViT under matched training conditions on a separate 300-image test set across ten random seeds. Triplet-ViT achieved 70.57% accuracy, compared with 71.0% for CE-only ViT. Triplet-ViT achieved 81.5% recall for Category C, which represented poorly differentiated organoids that were considered candidates for early exclusion from further culture, compared with 80.7% for CE-only ViT. EfficientNetV2-S and the ensemble achieved accuracies of 74.07% and 74.00%, respectively. The 50:50 ensemble of Triplet-ViT with EfficientNetV2-S achieved higher Category C recall, 83.80%, than EfficientNetV2-S alone, 82.50%. Advanced image-based deep learning, including triplet-trained models and their ensembles, may support nondestructive, standardized assessment of organoid differentiation, although independent validation across diverse cell lines and organoid systems is required before broader clinical application.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: